Open AccessOchrobactrum anthropi Bacteremia in a Non‐Diabetic, Immunocompetent Hemodialysis Patient
Author(s) -
Javaid Muhammad M.,
Rumjon Adam,
Cubbon Marc
Publication year - 2008
Publication title -
dialysis & transplantation
Language(s) - English
Resource type - Journals
eISSN - 1932-6920
pISSN - 0090-2934
DOI - 10.1002/dat.20277
Subject(s) - bacteremia , medicine , ciprofloxacin , immunosuppression , meropenem , hemodialysis , intensive care medicine , microbiology and biotechnology , surgery , immunology , antibiotics , antibiotic resistance , biology
Ochrobactrum anthropi is a rare human pathogen that is usually only associated with significant infection in immunocompromised, debilitated hosts with indwelling medical devices. It has rarely been implicated as a cause of bacteremia in hemodialysis (HD) patients. A review of the literature reveals only 2 reports of O. anthropi bacteremia in HD patients, all of whom were either diabetic or on therapeutic immunosuppression. We describe a case of O. anthropi bacteremia in an immunocompetent non‐diabetic HD patient and present a short review of the literature. Ciprofloxacin therapy failed to eradicate the infection despite in vitro susceptibility of the isolate. The organism subsequently developed resistance to ciprofloxacin and was only eradicated after removal of the patient's tunneled HD central venous catheter and treatment with IV meropenem.